Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
1.040
+0.020 (1.96%)
Dec 5, 2025, 4:00 PM EST - Market closed
Myomo Market Cap
Myomo has a market cap or net worth of $39.97 million as of December 5, 2025. Its market cap has decreased by -73.19% in one year.
Market Cap
39.97M
Enterprise Value
39.72M
1-Year Change
-73.19%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since June 30, 2017, Myomo's market cap has decreased from $66.00M to $39.97M, a decrease of -39.43%. That is a compound annual growth rate of -5.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 40.00M | -79.47% |
| Dec 31, 2024 | 194.80M | 46.69% |
| Dec 29, 2023 | 132.80M | 3,588.89% |
| Dec 30, 2022 | 3.60M | -92.34% |
| Dec 31, 2021 | 47.00M | 52.60% |
| Dec 31, 2020 | 30.80M | 492.31% |
| Dec 31, 2019 | 5.20M | -70.95% |
| Dec 31, 2018 | 17.90M | -21.83% |
| Dec 29, 2017 | 22.90M | -65.30% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |